Sort by:
Page 87 of 2922917 results

Comparative analysis of iterative vs AI-based reconstruction algorithms in CT imaging for total body assessment: Objective and subjective clinical analysis.

Tucciariello RM, Botte M, Calice G, Cammarota A, Cammarota F, Capasso M, Nardo GD, Lancellotti MI, Palmese VP, Sarno A, Villonio A, Bianculli A

pubmed logopapersJun 28 2025
This study evaluates the performance of Iterative and AI-based Reconstruction algorithms in CT imaging for brain, chest, and upper abdomen assessments. Using a 320-slice CT scanner, phantom images were analysed through quantitative metrics such as Noise, Contrast-to-Noise-Ratio and Target Transfer Function. Additionally, five radiologists performed subjective evaluations on real patient images by scoring clinical parameters related to anatomical structures across the three body sites. The study aimed to relate results obtained with the typical approach related to parameters involved in medical physics using a Catphan physical phantom, with the evaluations assigned by the radiologists to the clinical parameters chosen in this study, and to determine whether the physical approach alone can ensure the implementation of new procedures and the optimization in clinical practice. AI-based algorithms demonstrated superior performance in chest and abdominal imaging, enhancing parenchymal and vascular detail with notable reductions in noise. However, their performance in brain imaging was less effective, as the aggressive noise reduction led to excessive smoothing, which affected diagnostic interpretability. Iterative reconstruction methods provided balanced results for brain imaging, preserving structural details and maintaining diagnostic clarity. The findings emphasize the need for region-specific optimization of reconstruction protocols. While AI-based methods can complement traditional IR techniques, they should not be assumed to inherently improve outcomes. A critical and cautious introduction of AI-based techniques is essential, ensuring radiologists adapt effectively without compromising diagnostic accuracy.

Emerging Artificial Intelligence Innovations in Rheumatoid Arthritis and Challenges to Clinical Adoption.

Gilvaz VJ, Sudheer A, Reginato AM

pubmed logopapersJun 28 2025
This review was written to inform practicing clinical rheumatologists about recent advances in artificial intelligence (AI) based research in rheumatoid arthritis (RA), using accessible and practical language. We highlight developments from 2023 to early 2025 across diagnostic imaging, treatment prediction, drug discovery, and patient-facing tools. Given the increasing clinical interest in AI and its potential to augment care delivery, this article aims to bridge the gap between technical innovation and real-world rheumatology practice. Several AI models have demonstrated high accuracy in early RA detection using imaging modalities such as thermal imaging and nuclear scans. Predictive models for treatment response have leveraged routinely collected electronic health record (EHR) data, moving closer to practical application in clinical workflows. Patient-facing tools like mobile symptom checkers and large language models (LLMs) such as ChatGPT show promise in enhancing education and engagement, although accuracy and safety remain variable. AI has also shown utility in identifying novel biomarkers and accelerating drug discovery. Despite these advances, as of early 2025, no AI-based tools have received FDA approval for use in rheumatology, in contrast to other specialties. Artificial intelligence holds tremendous promise to enhance clinical care in RA-from early diagnosis to personalized therapy. However, clinical adoption remains limited due to regulatory, technical, and implementation challenges. A streamlined regulatory framework and closer collaboration between clinicians, researchers, and industry partners are urgently needed. With thoughtful integration, AI can serve as a valuable adjunct in addressing clinical complexity and workforce shortages in rheumatology.

Comprehensive review of pulmonary embolism imaging: past, present and future innovations in computed tomography (CT) and other diagnostic techniques.

Triggiani S, Pellegrino G, Mortellaro S, Bubba A, Lanza C, Carriero S, Biondetti P, Angileri SA, Fusco R, Granata V, Carrafiello G

pubmed logopapersJun 28 2025
Pulmonary embolism (PE) remains a critical condition that demands rapid and accurate diagnosis, for which computed tomographic pulmonary angiography (CTPA) is widely recognized as the diagnostic gold standard. However, recent advancements in imaging technologies-such as dual-energy computed tomography (DECT), photon-counting CT (PCD-CT), and artificial intelligence (AI)-offer promising enhancements to traditional diagnostic methods. This study reviews past, current and emerging technologies, focusing on their potential to optimize diagnostic accuracy, reduce contrast volumes and radiation doses, and streamline clinical workflows. DECT, with its dual-energy imaging capabilities, enhances image clarity even with lower contrast media volumes, thus reducing patient risk. Meanwhile, PCD-CT has shown potential for dose reduction and superior image resolution, particularly in challenging cases. AI-based tools further augment diagnostic speed and precision by assisting radiologists in image analysis, consequently decreasing workloads and expediting clinical decision-making. Collectively, these innovations hold promise for improved clinical management of PE, enabling not only more accurate diagnoses but also safer, more efficient patient care. Further research is necessary to fully integrate these advancements into routine clinical practice, potentially redefining diagnostic workflows for PE and enhancing patient outcomes.

Automated Evaluation of Female Pelvic Organ Descent on Transperineal Ultrasound: Model Development and Validation.

Wu S, Wu J, Xu Y, Tan J, Wang R, Zhang X

pubmed logopapersJun 28 2025
Transperineal ultrasound (TPUS) is a widely used tool for evaluating female pelvic organ prolapse (POP), but its accurate interpretation relies on experience, causing diagnostic variability. This study aims to develop and validate a multi-task deep learning model to automate POP assessment using TPUS images. TPUS images from 1340 female patients (January-June 2023) were evaluated by two experienced physicians. The presence and severity of cystocele, uterine prolapse, rectocele, and excessive mobility of perineal body (EMoPB) were documented. After preprocessing, 1072 images were used for training and 268 for validation. The model used ResNet34 as the feature extractor and four parallel fully connected layers to predict the conditions. Model performance was assessed using confusion matrix and area under the curve (AUC). Gradient-weighted class activation mapping (Grad-CAM) visualized the model's focus areas. The model demonstrated strong diagnostic performance, with accuracies and AUC values as follows: cystocele, 0.869 (95% CI, 0.824-0.905) and 0.947 (95% CI, 0.930-0.962); uterine prolapse, 0.799 (95% CI, 0.746-0.842) and 0.931 (95% CI, 0.911-0.948); rectocele, 0.978 (95% CI, 0.952-0.990) and 0.892 (95% CI, 0.849-0.927); and EMoPB, 0.869 (95% CI, 0.824-0.905) and 0.942 (95% CI, 0.907-0.967). Grad-CAM heatmaps revealed that the model's focus areas were consistent with those observed by human experts. This study presents a multi-task deep learning model for automated POP assessment using TPUS images, showing promising efficacy and potential to benefit a broader population of women.

Developing ultrasound-based machine learning models for accurate differentiation between sclerosing adenosis and invasive ductal carcinoma.

Liu G, Yang N, Qu Y, Chen G, Wen G, Li G, Deng L, Mai Y

pubmed logopapersJun 28 2025
This study aimed to develop a machine learning model using breast ultrasound images to improve the non-invasive differential diagnosis between Sclerosing Adenosis (SA) and Invasive Ductal Carcinoma (IDC). 2046 ultrasound images from 772 SA and IDC patients were collected, Regions of Interest (ROI) were delineated, and features were extracted. The dataset was split into training and test cohorts, and feature selection was performed by correlation coefficients and Recursive Feature Elimination. 10 classifiers with Grid Search and 5-fold cross-validation were applied during model training. Receiver Operating Characteristic (ROC) curve and Youden index were used to model evaluation. SHapley Additive exPlanations (SHAP) was employed for model interpretation. Another 224 ROIs of 84 patients from other hospitals were used for external validation. For the ROI-level model, XGBoost with 18 features achieved an area under the curve (AUC) of 0.9758 (0.9654-0.9847) in the test cohort and 0.9906 (0.9805-0.9973) in the validation cohort. For the patient-level model, logistic regression with 9 features achieved an AUC of 0.9653 (0.9402-0.9859) in the test cohort and 0.9846 (0.9615-0.9978) in the validation cohort. The feature "Original shape Major Axis Length" was identified as the most important, with its value positively correlated with a higher likelihood of the sample being IDC. Feature contributions for specific ROIs were visualized as well. We developed explainable, ultrasound-based machine learning models with high performance for differentiating SA and IDC, offering a potential non-invasive tool for improved differential diagnosis. Question Accurately distinguishing between sclerosing adenosis (SA) and invasive ductal carcinoma (IDC) in a non-invasive manner has been a diagnostic challenge. Findings Explainable, ultrasound-based machine learning models with high performance were developed for differentiating SA and IDC, and validated well in external validation cohort. Critical relevance These models provide non-invasive tools to reduce misdiagnoses of SA and improve early detection for IDC.

Identifying visible tissue in intraoperative ultrasound: a method and application.

Weld A, Dixon L, Dyck M, Anichini G, Ranne A, Camp S, Giannarou S

pubmed logopapersJun 28 2025
Intraoperative ultrasound scanning is a demanding visuotactile task. It requires operators to simultaneously localise the ultrasound perspective and manually perform slight adjustments to the pose of the probe, making sure not to apply excessive force or breaking contact with the tissue, while also characterising the visible tissue. To analyse the probe-tissue contact, an iterative filtering and topological method is proposed to identify the underlying visible tissue, which can be used to detect acoustic shadow and construct confidence maps of perceptual salience. For evaluation, datasets containing both in vivo and medical phantom data are created. A suite of evaluations is performed, including an evaluation of acoustic shadow classification. Compared to an ablation, deep learning, and statistical method, the proposed approach achieves superior classification on in vivo data, achieving an <math xmlns="http://www.w3.org/1998/Math/MathML"><msub><mi>F</mi> <mi>β</mi></msub> </math> score of 0.864, in comparison with 0.838, 0.808, and 0.808. A novel framework for evaluating the confidence estimation of probe-tissue contact is created. The phantom data are captured specifically for this, and comparison is made against two established methods. The proposed method produced the superior response, achieving an average normalised root-mean-square error of 0.168, in comparison with 1.836 and 4.542. Evaluation is also extended to determine the algorithm's robustness to parameter perturbation, speckle noise, data distribution shift, and capability for guiding a robotic scan. The results of this comprehensive set of experiments justify the potential clinical value of the proposed algorithm, which can be used to support clinical training and robotic ultrasound automation.

Prognostic value of body composition out of PSMA-PET/CT in prostate cancer patients undergoing PSMA-therapy.

Roll W, Plagwitz L, Ventura D, Masthoff M, Backhaus C, Varghese J, Rahbar K, Schindler P

pubmed logopapersJun 28 2025
This retrospective study aims to develop a deep learning-based approach to whole-body CT segmentation out of standard PSMA-PET-CT to assess body composition in metastatic castration resistant prostate cancer (mCRPC) patients prior to [<sup>177</sup>Lu]Lu-PSMA radioligand therapy (RLT). Our goal is to go beyond standard PSMA-PET-based pretherapeutic assessment and identify additional body composition metrics out of the CT-component, with potential prognostic value. We used a deep learning segmentation model to perform fully automated segmentation of different tissue compartments, including visceral- (VAT), subcutaneous- (SAT), intra/intermuscular- adipose tissue (IMAT) from [<sup>68</sup> Ga]Ga-PSMA-PET-CT scans of n = 86 prostate cancer patients before RLT. The proportions of different adipose tissue compartments to total adipose tissue (TAT) assessed on a 3D CT-volume of the abdomen or on a 2D single slice basis (centered at third lumbal vertebra (L3)) were compared for their prognostic value. First, univariate and multivariate Cox proportional hazards regression analyses were performed. Subsequently, the subjects were dichotomized at the median tissue composition, and these subgroups were evaluated by Kaplan-Meier analysis with the log-rank test. The automated segmentation model was useful for delineating different adipose tissue compartments and skeletal muscle across different patient anatomies. Analyses revealed significant correlations between lower SAT and higher IMAT ratios and poorer therapeutic outcomes in Cox regression analysis (SAT/TAT: p = 0.038; IMAT/TAT: p < 0.001) in the 3D model. In the single slice approach only IMAT/SAT was significantly associated with survival in Cox regression analysis (p < 0.001; SAT/TAT: p > 0.05). IMAT ratio remained an independent predictor of survival in multivariate analysis when including PSMA-PET and blood-based prognostic factors. In this proof-of-principle study the implementation of a deep learning-based whole-body analysis provides a robust and detailed CT-based assessment of body composition in mCRPC patients undergoing RLT. Potential prognostic parameters have to be corroborated in larger prospective datasets.

Prompt Mechanisms in Medical Imaging: A Comprehensive Survey

Hao Yang, Xinlong Liang, Zhang Li, Yue Sun, Zheyu Hu, Xinghe Xie, Behdad Dashtbozorg, Jincheng Huang, Shiwei Zhu, Luyi Han, Jiong Zhang, Shanshan Wang, Ritse Mann, Qifeng Yu, Tao Tan

arxiv logopreprintJun 28 2025
Deep learning offers transformative potential in medical imaging, yet its clinical adoption is frequently hampered by challenges such as data scarcity, distribution shifts, and the need for robust task generalization. Prompt-based methodologies have emerged as a pivotal strategy to guide deep learning models, providing flexible, domain-specific adaptations that significantly enhance model performance and adaptability without extensive retraining. This systematic review critically examines the burgeoning landscape of prompt engineering in medical imaging. We dissect diverse prompt modalities, including textual instructions, visual prompts, and learnable embeddings, and analyze their integration for core tasks such as image generation, segmentation, and classification. Our synthesis reveals how these mechanisms improve task-specific outcomes by enhancing accuracy, robustness, and data efficiency and reducing reliance on manual feature engineering while fostering greater model interpretability by making the model's guidance explicit. Despite substantial advancements, we identify persistent challenges, particularly in prompt design optimization, data heterogeneity, and ensuring scalability for clinical deployment. Finally, this review outlines promising future trajectories, including advanced multimodal prompting and robust clinical integration, underscoring the critical role of prompt-driven AI in accelerating the revolution of diagnostics and personalized treatment planning in medicine.

Non-contrast computed tomography radiomics model to predict benign and malignant thyroid nodules with lobe segmentation: A dual-center study.

Wang H, Wang X, Du YS, Wang Y, Bai ZJ, Wu D, Tang WL, Zeng HL, Tao J, He J

pubmed logopapersJun 28 2025
Accurate preoperative differentiation of benign and malignant thyroid nodules is critical for optimal patient management. However, conventional imaging modalities present inherent diagnostic limitations. To develop a non-contrast computed tomography-based machine learning model integrating radiomics and clinical features for preoperative thyroid nodule classification. This multicenter retrospective study enrolled 272 patients with thyroid nodules (376 thyroid lobes) from center A (May 2021-April 2024), using histopathological findings as the reference standard. The dataset was stratified into a training cohort (264 lobes) and an internal validation cohort (112 lobes). Additional prospective temporal (97 lobes, May-August 2024, center A) and external multicenter (81 lobes, center B) test cohorts were incorporated to enhance generalizability. Thyroid lobes were segmented along the isthmus midline, with segmentation reliability confirmed by an intraclass correlation coefficient (≥ 0.80). Radiomics feature extraction was performed using Pearson correlation analysis followed by least absolute shrinkage and selection operator regression with 10-fold cross-validation. Seven machine learning algorithms were systematically evaluated, with model performance quantified through the area under the receiver operating characteristic curve (AUC), Brier score, decision curve analysis, and DeLong test for comparison with radiologists interpretations. Model interpretability was elucidated using SHapley Additive exPlanations (SHAP). The extreme gradient boosting model demonstrated robust diagnostic performance across all datasets, achieving AUCs of 0.899 [95% confidence interval (CI): 0.845-0.932] in the training cohort, 0.803 (95%CI: 0.715-0.890) in internal validation, 0.855 (95%CI: 0.775-0.935) in temporal testing, and 0.802 (95%CI: 0.664-0.939) in external testing. These results were significantly superior to radiologists assessments (AUCs: 0.596, 0.529, 0.558, and 0.538, respectively; <i>P</i> < 0.001 by DeLong test). SHAP analysis identified radiomic score, age, tumor size stratification, calcification status, and cystic components as key predictive features. The model exhibited excellent calibration (Brier scores: 0.125-0.144) and provided significant clinical net benefit at decision thresholds exceeding 20%, as evidenced by decision curve analysis. The non-contrast computed tomography-based radiomics-clinical fusion model enables robust preoperative thyroid nodule classification, with SHAP-driven interpretability enhancing its clinical applicability for personalized decision-making.

Cardiac Measurement Calculation on Point-of-Care Ultrasonography with Artificial Intelligence

Mercaldo, S. F., Bizzo, B. C., Sadore, T., Halle, M. A., MacDonald, A. L., Newbury-Chaet, I., L'Italien, E., Schultz, A. S., Tam, V., Hegde, S. M., Mangion, J. R., Mehrotra, P., Zhao, Q., Wu, J., Hillis, J.

medrxiv logopreprintJun 28 2025
IntroductionPoint-of-care ultrasonography (POCUS) enables clinicians to obtain critical diagnostic information at the bedside especially in resource limited settings. This information may include 2D cardiac quantitative data, although measuring the data manually can be time-consuming and subject to user experience. Artificial intelligence (AI) can potentially automate this quantification. This study assessed the interpretation of key cardiac measurements on POCUS images by an AI-enabled device (AISAP Cardio V1.0). MethodsThis retrospective diagnostic accuracy study included 200 POCUS cases from four hospitals (two in Israel and two in the United States). Each case was independently interpreted by three cardiologists and the device for seven measurements (left ventricular (LV) ejection fraction, inferior vena cava (IVC) maximal diameter, left atrial (LA) area, right atrial (RA) area, LV end diastolic diameter, right ventricular (RV) fractional area change and aortic root diameter). The endpoints were the root mean square error (RMSE) of the device compared to the average cardiologist measurement (LV ejection fraction and IVC maximal diameter were primary endpoints; the other measurements were secondary endpoints). Predefined passing criteria were based on the upper bounds of the RMSE 95% confidence intervals (CIs). The inter-cardiologist RMSE was also calculated for reference. ResultsThe device achieved the passing criteria for six of the seven measurements. While not achieving the passing criterion for RV fractional area change, it still achieved a better RMSE than the inter-cardiologist RMSE. The RMSE was 6.20% (95% CI: 5.57 to 6.83; inter-cardiologist RMSE of 8.23%) for LV ejection fraction, 0.25cm (95% CI: 0.20 to 0.29; 0.36cm) for IVC maximal diameter, 2.39cm2 (95% CI: 1.96 to 2.82; 4.39cm2) for LA area, 2.11cm2 (95% CI: 1.75 to 2.47; 3.49cm2) for RA area, 5.06mm (95% CI: 4.58 to 5.55; 4.67mm) for LV end diastolic diameter, 10.17% (95% CI: 9.01 to 11.33; 14.12%) for RV fractional area change and 0.19cm (95% CI: 0.16 to 0.21; 0.24cm) for aortic root diameter. DiscussionThe device accurately calculated these cardiac measurements especially when benchmarked against inter-cardiologist variability. Its use could assist clinicians who utilize POCUS and better enable their clinical decision-making.
Page 87 of 2922917 results
Show
per page

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.